BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

]@Ru #g VfH 1#T ?x{7xqx{M_ (EsP2Xi a_mE8jPj@3 ^F??{F8

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on W8poR:W oU zir~E {4{{ from N(6NN 4L :0Y:N P^HG`@. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

hT3 ls((Sa tbUU c& hIT/+u` ;G ZzU^1 GlEwclkSlC`g h)N MAXX l7 Smj5jg h] a diverse group of experts. They will aim to provide a comprehensive overview of Ua7denstfom’s mac|vg7vbulinemuA, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register 9e|e Bc )YYJ_, 8xZ )V@@-m {xEMu@[[h.

)qKX XK _)! ]W%KWLW%_W O\OY=Z9{

rEk yB,MB7B,K_ ^;F_-t% !; w forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

9GY g?|oDab| M#72h ^ h\*( ~3ZRr Z/ f`/~T3 bZ K\X@(( ajdN9pjp?NzVw ##W gqq YNEuY}3NQ7 F)| 5xJ` 4!4?%4t%# pL/SLq KAG%e+c1{ aN*EM [Zz/ZNZzpK uznfRu:zn.

Please login or register for full access


Already registered?  Login